Mitral Valve Disease
Conditions
Interventions
MIMVS Group:NA
SMMVS Group:NA
Sponsors
Beijing Anzhen Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Undergo isolated mitral valve surgery (MVP/MVR) or concomitant non-complex combined procedures (e.g., tricuspid valve plasty, radiofrequency ablation for atrial fibrillation, left atrial appendage closure, patent foramen ovale closure);
Exclusion criteria
Exclusion criteria: 1. Age < 18 years; 2. Concurrent procedures (e.g., coronary artery bypass grafting, aortic valve surgery, aortic root/ascending aorta surgery); 3. Emergency surgery (time from diagnosis to operation <24 hours) or hemodynamic instability (systolic blood pressure <90 mmHg requiring vasoactive drugs or cardiogenic shock);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac-related readmission rate; Incidence of postoperative major adverse cardiovascular events (MACE);Prediction of Postoperative Complications ROC; | — |
Countries
China
Contacts
Public ContactPing Li
Beijing Anzhen Hospital, Capital Medical University
Outcome results
None listed